Aplastic Anemia & MDS International Foundation (AAMDSIF) 2023 PNH

Aplastic Anemia & MDS International Foundation (AAMDSIF) 2023

Plain Language Poster: Human Factors Validation Study for a Wearable, Single-Use Injection Device for Pegcetacoplan

Safety and Effectiveness of Pegcetacoplan for Adults With Paroxysmal Nocturnal Hemoglobinuria: A Plain Language Summary of the First 48 Weeks of Study 307

Access Resources

Pegcetacoplan in Patients With Paroxysmal Nocturnal Hemoglobinuria and Aplastic Anemia in the PRINCE Study

Access Resources

Evaluation of Pegcetacoplan in Paroxysmal Nocturnal Hemoglobinuria Patients with Aplastic Anemia

Access Resources

The following information is available for educational purposes only. The information is not to be re-purposed or re-used in its current form or presentation for any personal or professional use. Apellis reserves the right to withdraw, modify or change the information that is available on this website at any time.

The safety and efficacy of the agents under investigation have not been established. There is no guarantee that the agents will receive regulatory approval and become commercially available fo rthe uses being investigated.